Research article summary (published 21 May 2003):

[Can insulin humalog be given during pregnancy?]

(Kann Insulin Humalog in der Schwangerschaft gegeben werden?)

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Scherbaum, W A (WA);

Affiliation: Deutsches Diabetes Forschungsinstitut, Heinrich-Heine-Universität, Düsseldorf.

Journal and publication information

Publication Type: Case Reports; Journal Article

Journal: Deutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr), published in Germany. (Language: ger)

Reference: 2003-May; vol 128 (issue 21) : pp 1190

Dates: Created 2003/05/22; Completed 2003/06/19; Revised 2004/11/17;

PMID: 12761695, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Abnormalities, Drug-Induced - etiology Diabetes Mellitus, Type 1 - drug therapy Female Hemoglobin A, Glycosylated - analysis Humans

Hypoglycemic Agents - adverse effects; therapeutic use Insulin - adverse effects; analogs & derivatives; therapeutic use Pregnancy Pregnancy in Diabetics - drug therapy Risk Factors

Associated Chemicals: Hemoglobin A, Glycosylated (0) ; Hypoglycemic Agents (0) ; Insulin (11061-68-0) ; insulin LISPRO (133107-64-9)

Related articles

These are the highest related articles currently in the database:

• Congenital malformations in pregnancies complicated by NIDDM. 30 Oct 1995
• Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. 29 Apr 1999
• Insulin lispro and regular insulin in pregnancy. 29 Apr 2001
• Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. 29 Sep 2003
• [The frequency of mild and severe fetal malformations in diabetic women with high values of glycosilated hemoglobin in early pregnancy] 30 Dec 2004
• The insulin analog glargine during an unplanned pregnancy. 29 Sep 2006
• Fetal growth in women managed with insulin pump therapy compared to conventional insulin. 12 Nov 2007
• Insulin-dependent diabetes mellitus in which glycemic control was improved during pregnancy but deteriorated after delivery with the occurrence of postpartum thyrotoxicosis: a case report. 30 Aug 1991
• Insulin antibodies do not preclude optimization of metabolic control in women with IDDM during pregnancy. 30 Aug 1996

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.